ab 13 August 2024 Global Research and Evidence Lab YES Powered by UBS Evidence Lab Initiation of Coverage | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------|-------|---------|--------|--------|------------------------------------------|----------- ...

Xylem beat second-quarter estimates, but investors were not impressed. As a result, the stock finished the day down 5.7% on Tuesday. Revenue in the quarter jumped 26% or 9% organically, reaching $2.17 billion and topping estimates of $2.14 billion. The organic results exclude the impact of its acquisition of Evoqua Water Technologies. What's next for Xylem Xylem might have gained on today's news, but the stock was already up roughly 20% year to date and trades at a forward price-to-earnings ratio of more th ...

XYL's revenues of $2.17 billion beat the consensus estimate of $2.16 billion. The top line jumped 26% year over year, driven by strong commercial and operational execution, and resilient demand. Organic revenues in the quarter rose 9%. Segmental Details The Applied Water segment generated revenues of $456 million, down 5% year over year. Organic sales fell 4% on a year-over-year basis. The segmental performance was hurt by softness in developed markets and an unfavorable mix. The Zacks Consensus Estimate wa ...

| --- | --- | --- | |--------------------------------------------------------------------------------------------------------|----------|---------------------------------------------| | (in millions) \nXylem Common Stock issued to Evoqua stockholders (58,779,096 shares) | Fair \n$ | Value of Purchase Consideration \n6,121 | | Estimated replacement equity awards | | 160 | | Payment of certain Evoqua indebtedness | | 619 | | Total | $ | 6,900 | 9 | --- | --- | --- | --- | --- | |------------------------------ ...

Xylem Inc. (NYSE:XYL) Q2 2024 Earnings Conference Call July 30, 2024 9:00 AM ET Company Participants Andrea van der Berg - Vice President, Investor Relations Matthew Pine - Chief Executive Officer Bill Grogan - Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets Mike Halloran - Robert W. Baird Scott Davis - Melius Research Nathan Jones - Stifel Nicolaus Joseph Giordano - TD Cowen Andrew Kaplowitz - Citigroup Bryan Blair - Oppenheimer Operator Good day, everyone, and welcome ...

Xylem (XYL) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for nonrecurring items. Over the last four quarters, the company has surpassed consensus EPS estimates four times. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earning ...

Industrial and buildings solutions applications including pumps, valves, heat exchangers, controls, and dispensing equipment • Key Brands: Bell & Gossett, Flojet, Goulds, Lowara • Geo. Split: US ~50% / W. Europe ~20% / EM & Other ~30% • End Market Split: Industrials ~45% / Building Solutions ~55% • Channels: Primarily indirect • Market Drivers: Urbanization, climate, regulation, labor shortage • Competitive Advantage: Established footprint, strong channel partnerships, quality & reliability Water Infrastruc ...

Xylem Reports Second Quarter 2024 Results and Raises Full-Year Guidance • Revenue of $2.2 billion, up 26% on a reported basis and 9% organically • Earnings per share of $0.80, up 78%; $1.09 on an adjusted basis, up 11% • Raising full-year revenue guidance to $8.55 billion, up approximately 16%, with organic revenue growth of 5% to 6%, up from 4% to 6% • Increasing full-year adjusted EPS guidance to $4.18 to $4.28, from $4.10 to $4.25 WASHINGTON, D.C., (July 30, 2024) – Xylem Inc. (NYSE: XYL), a leading glob ...

The consensus EPS estimate for the quarter has undergone a downward revision of 0.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. In light of this perspective, let's dive into the average estimates of certain Xylem metrics that are commonly tracked and forecasted by Wall Street analysts. Analysts forecast 'Revenue- Measurement & Control Solutions' to reach $470.39 million. The esti ...

Let's see how things have shaped up for Xylem this earnings season. Growth in the transport application business, driven by backlog execution and the timing of projects in Western Europe, is expected to have boosted the Water Infrastructure segment's performance. The Water Solutions and Services segment is anticipated to have performed strongly, driven by strength in the dewatering application business. Earnings Whispers The company has a stellar earnings surprise history, having outperformed the Zacks Cons ...